Decoy Therapeutics (DCOY) Current Deferred Revenue (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Current Deferred Revenue of $3.2 million for Q1 2026, little changed quarter-over-quarter from $3.2 million in Q4 2025.
Decoy Therapeutics (DCOY) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Current Deferred Revenue for 8 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (changed N/A YoY), while the FY2025 annual figure was $3.2 million, changed N/A from the prior year.
- Current Deferred Revenue was little changed at $3.2 million in Q1 2026 per DCOY's latest filing, from $3.2 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $3.2 million in Q4 2025 and bottomed at $3.2 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 3.23 Mn |
| Dec 31, 2019 | 1.00 Mn |
| Sep 30, 2019 | 2.00 Mn |
| Dec 31, 2018 | 4.10 Mn |
| Sep 30, 2018 | 53,919.00 |
| Mar 31, 2018 | 58,821.00 |
| Dec 31, 2017 | 58,821.00 |
| Sep 30, 2017 | 58,821.00 |
| Mar 31, 2017 | 7,579.00 |
| Dec 31, 2016 | 21,095.00 |
| Sep 30, 2016 | 25,351.00 |
| Jun 30, 2016 | 65,115.00 |
| Mar 31, 2016 | 24,174.00 |
| Sep 30, 2015 | 21,881.00 |
| Jun 30, 2015 | 21,881.00 |
| Mar 31, 2015 | 21,881.00 |
| Dec 31, 2014 | 21,881.00 |